Monitoring severe bacterial infections in hospitalized children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prevalence and characteristics of severe community-acquired invasive bacterial infections in children admitted to pediatric intensive care units. It will document clinical, biological, and microbiological data related to these infections, providing insights into their management. The study is crucial for understanding the epidemiology of these infections in France, where no current monitoring exists. By gathering this data, the study seeks to enhance prevention strategies for severe bacterial infections in hospitalized children.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \<18 years (only hospitalized children)
* Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment).

Exclusion Criteria:

* Refusal by one of the parents or by Child in understanding age
* Nosocomial infection

Where it's running

• Association Clinique Thérapeutique Infantile du val de Marne
  Créteil, France Recruiting

Study contacts

• Principal investigator: Michael Levy — CHU Robert Debré, Paris
• Study coordinator: Corinne Levy
• Email: corinne.levy@activ-france.fr
• Phone: 1 48 85 04 04

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Infectious complications in blood cancer patients treated with bispecific antibodies

  This study tests how often infections occur in adults with blood cancers who are being treated with bispecific antibodies.

  Recruiting at 2 sites Infanta Leonor University Hospital · Madrid, Madrid and 1 other locations · NCT07609576

• N-acetylcysteine for severe infection with liver dysfunction in adults

  In adults with acute infection or sepsis and liver dysfunction, this study tests whether giving N-acetylcysteine in a four-hour infusion improves days alive and out of the hospital in the first 14 days.

  Recruiting Phase 4 University Hospital Bispebjerg and Frederiksberg · Copenhagen · NCT07273071

• New care guideline for infants 60 days and younger with fever in Sweden

  This project will test a new guideline to see if infants 60 days or younger with fever can safely avoid many invasive tests, hospital stays, and broad antibiotics compared with usual care.

  Recruiting at 9 sites Region Skane · Gothenburg and 10 other locations · NCT07134751

• Improving how feeding tubes are placed in children using proven best practices.

  This project will try updated evidence-based methods and nurse education to improve feeding tube placement for hospitalized children.

  Recruiting at 22 sites Children's Hospital of Fudan University · Shanghai, Minhang and 21 other locations · NCT07038538

• Continuous infusion vs intermittent dosing of ceftazidime/avibactam in critically ill patients

  This study tests whether giving ceftazidime/avibactam as a continuous infusion works better than standard intermittent dosing for seriously ill ICU patients with certain resistant infections.

  Recruiting Phase 4 Clinical Hospital Centre Zagreb · Zagreb · NCT06811727

• Descriptive study of severe infections treated with phage therapy

  This study looks at how well phage therapy works for people with severe infections by gathering information from 250 patients treated at a hospital in Lyon.

  Recruiting Hospices Civils de Lyon · Lyon · NCT06185920

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.